Who: support Beijing to investigate a suspected vaccine adverse reaction | | who country health npfpc | vaccine _ news

Authorities wide nets in Beijing, December 29 (reporter Shen Jingwen) according to the voice of the Yonge-Canton News reported, the State food and Drug Administration recently has informed the World Health Organization in my country recently suspected hepatitis b vaccination of abnormal reaction of the situation. The who expressed concern, supporting China's investigation.

After receiving China briefing, who representative in China Shi Hede to Chinese Government's timely and effective reporting and investigative work gave a full affirmation, and expressed its willingness to investigate this incident provided the support and help that China needs.

Who subsequently published who's concern and support the investigation of suspected adverse reaction after vaccination textual declarations, said in a statement, the who and the Chinese Government, also concerned about recent reports that several suspected neonatal hepatitis b vaccine deaths. China National Commission of health and the State food and Drug Administration is investigating whether the vaccine caused 7 deaths. Another newborn had recovered and been discharged, these 8 cases occurred in 3 different departments, but the vaccines from a production company. These cases has prompted the food and drug administration and the National Health Commission suspended the vaccines business decisions of the hepatitis b vaccine. Incidents under investigation, who supports this decision.

Also mentioned in the statement, hepatitis b is a potentially fatal liver infection, and may lead to chronic liver disease and chronic hepatitis b virus infection, increased risk of cirrhosis and liver cancer mortality. Hepatitis b vaccine is the best way to prevent infection, according to who guidelines, every newborn in China received the first dose of hepatitis b vaccine within 24 hours of birth, in January and June age vaccinated with two doses of hepatitis b vaccine.

In general the hepatitis b vaccine is safe and effective, China's hepatitis b vaccine immunization programme has been that children under 5 years of age for hepatitis b virus infection from hepatitis b immunization programme prior to the implementation of more than 9% down to now less than cent. Future generations who will continue to maintain a national health and family planning, as well as close cooperation with the food and drug administration, according to the investigative work needed to support this event, and to ensure that during this time provide the best guide to immunization for parents and recommendations.

(Original title: who supports the Chinese investigation into the suspected vaccine adverse reaction)

(Edit: SN098)
December 29, 2013 China broadcast network
(
世卫组织:支持中方调查疑似疫苗接种异常反应|世卫组织|国家卫生计生委|疫苗_新闻资讯

　　央广网北京12月29日消息(记者沈静文) 据中国之声《央广新闻》报道，国家食品药品监督管理总局日前正式向世界卫生组织通报了近日在我国发生的疑似乙肝疫苗预防接种异常反应的有关情况。世卫组织对此表示关注，支持中方的调查。

　　在接到中方通报之后，世卫组织驻华代表施贺德博士对中国政府及时有效的报告和调查等工作给予了充分的肯定，并表示愿意为调查这一事件提供中国所需的各项支持和帮助。

　　世卫组织随后也发布了世卫组织关注和支持对疑似预防接种异常反应的调查的文字声明，声明称，世卫组织和中国政府一样，也在关注最近报道的几起疑似新生儿接种乙肝疫苗致死事件。中国国家卫生计生委和国家食品药品监管总局正在调查是否因疫苗导致这7起死亡事件。另一名新生儿已康复出院，这8个病例发生在3个不同省份，但是疫苗来自同一家生产企业。这几起病例已促使食药监管总局与国家卫生计生委做出暂停使用该疫苗企业的乙肝疫苗的决定。事件在调查当中，世卫组织支持这一决定。

　　声明中同时提及，乙型肝炎是一种可能致命肝脏感染，乙肝病毒可能引发慢性肝病以及慢性感染，增加肝硬化和肝癌的死亡风险。接种乙肝疫苗是预防感染的最佳方式，按照世卫组织的指南，中国每一名新生儿在出生后24小时之内接受第一剂乙肝疫苗，在一月龄和六月龄分别接种另两剂乙肝疫苗。

　　总的来说乙肝疫苗是安全有效的，中国的乙肝疫苗免疫规划项目已经使5岁以下的儿童乙肝病毒感染率从乙肝免疫规划项目实施前的超过9%降低到了现在的不到1%。而今后世卫组织也将继续保持和国家卫生计生委以及食药监管总局的密切合作，根据需要支持此事件的调查工作，并确保在此期间为家长们提供免疫的最佳指南和建议。

(原标题：世卫组织支持中方对疑似疫苗接种异常反应的调查)

（编辑：SN098）
2013年12月29日11:33
中国广播网
)